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Abstract
To add new tools to the repertoire of protein-based multivalent scaffold design, we have developed a novel dual-labeling strategy
for proteins that combines residue-specific incorporation of unnatural amino acids with chemical oxidative aldehyde formation at
the N-terminus of a protein. Our approach relies on the selective introduction of two different functional moieties in a protein by
mutually orthogonal copper-catalyzed azide–alkyne cycloaddition (CuAAC) and oxime ligation. This method was applied to the
conjugation of biotin and β-linked galactose residues to yield an enzymatically active thermophilic lipase, which revealed specific
binding to Erythrina cristagalli lectin by SPR binding studies.
Introduction
The chemical modification of proteins has been developed to a
core discipline in chemical biology with diverse applications in
all areas of the life sciences, including pharmacology,
biophysics, biotechnology and cell biology [1-4]. In addition to
the use of chemical labeling methods to study structure and
function of proteins in vitro and in vivo, chemoselective conju-
gation techniques are also used to functionalize artificial protein
scaffolds, such as viral capsids [5-7]. Such templates have self-
assembled hierarchical structures that allow the generation of
nanostructured scaffolds with precisely defined dimensions and
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configurations [7-12]. We have recently contributed to this field
using globular proteins as multivalent scaffolds for the struc-
turally-defined presentation of ligands. In a proof-of-principle
study to engineer multivalent glycoprotein conjugates, we have
used the incorporation of non-canonical amino acids (NCAA)
[13] by supplementation based incorporation (SPI) [14-17] in
auxotroph expression systems followed by the chemoselective
Cu-catalyzed azide–alkyne cycloaddition (CuAAC) to attach
carbohydrate ligands to the protein barstar [18].
In the current study, we aimed to extend this approach to the
dual modification of proteins using a combination of two
chemoselective, orthogonal conjugation reactions for the intro-
duction of glycan ligands and biotin to a protein. Our main
objective in this paper was the development of a robust syn-
thetic methodology that allows the site-specific attachment of
two distinct chemical modifications to a given protein, which
can be used to target multivalent interactions. As a protein scaf-
fold we selected the thermophilic lipase from Thermoanaero-
bacter thermohydrosulfuricus (TTL), since this protein is
tolerant to high temperatures, a variety of solvents and other
additives, and an enzymatic assay is available as a control for
retained protein integrity and catalytic function [19].
Dual labeling techniques in protein synthesis are dependent on
the availability of unnatural protein expression methods to
install orthogonal chemical handles for subsequent biorthog-
onal modification reactions [20,21]. For instance, the groups of
Chin, Liu and Lemke introduced two mutually compatible
chemical handles by combining nonsense and/or quadruplet
codon suppressions [22-25]. Although recombinant expression
strains have been engineered to improve incorporation effi-
ciency [26-28], double labeling approaches by nonsense or
quadruplet codon suppression are often coping with low protein
yields. The main reasons for these low yields are the competi-
tion of NCAA incorporation with translational frame shifting or
termination, and low catalytic efficiency of engineered
aminoacyl-tRNA synthetases [29].
Certainly, the most straightforward approach to achieve the dual
modification of proteins is to combine unnatural protein expres-
sion with the site-directed modification of canonical amino
acids, particularly cysteine. For example, SPI was used to intro-
duce a NCAA such as azidohomoalanine (Aha) in a methio-
nine-(Met)-auxotroph in combination with the chemical modifi-
cation of the natural amino acid cysteine [30,31]. These handles
were, e.g., addressed by CuAAC and disulfide bond formation,
respectively, to introduce two distinct modifications. In addi-
tion also amber suppression for the installation of a ketone-
containing NCAA (Ac-Phe) was combined with Cys-labeling
for a site-specific FRET-labeling of proteins [32]. Despite these
advances, the chemical modification of cysteine has some draw-
backs including the high tendency for disulfide bond formation
or cross reaction with other cysteine residues, reaction revers-
ibility, and occasionally side-reactions with basic side chains,
e.g., lysines [33].
Specifically, in the current paper we use in the current paper the
oxime ligation [34,35] as the second orthogonal conjugation
reaction in addition to CuAAC for the attachment of functional
moieties to Aha residues installed by auxotroph expression. In
order to install a second unnatural functionality in the protein,
in addition to SPI, we utilized the well-established oxidative
aldehyde formation at the N-terminus with NaIO4 [36-41]. With
this approach, we aimed to engineer an artificial lectin-binding
protein via chemical installation of several galactose moieties
by CuAAC [18]. The second functionalization site at the
protein’s N-terminus was conjugated with biotin using oxime
ligation, by which the protein scaffold was immobilized on a
streptavidin gold chip to monitor carbohydrate–protein binding
studies by surface plasmon resonance (SPR). This immobili-
zation strategy allowed easy handling and reproducible orienta-
tion, which are notable improvements over the alternative active
ester immobilization. Although not directly demonstrated in the
current paper, our approach required considerably lower
amounts of the inhibiting glycoconjugate in comparison to the
reverse approach, which involves immobilization of lectin and
titration of the binder.
Results and Discussion
Protein design
Aha labelled TTL variants were always expressed with the SPI
approach. Aha is a Met analogue and incorporation leads to full
substitution of all Met residues in TTL by Aha residues. Six of
the ten Met positions are solvent accessible (M1,M20, M21,
M145, M150, M161) [42]. These positions are well distributed
over the protein surface. In addition to the reasons stated in the
introduction, the Met surface distribution made TTL an attrac-
tive choice for this proof-of-principle study to generate a
double-functionalized protein scaffold for multivalent binding
studies.
In the beginning of our studies, we expressed TTL recombi-
nantly with an N-terminal His-tag and tobacco etch virus
protease (TEV) cleavage site, leaving an N-terminal Ser after
the cleavage. However, we were unable to cleave the tag. This
is probably due to structural constraints at the TTL’s
N-terminus leaving the TEV protease recognition site inacces-
sible for the protease (for more information on protein design
see Supporting Information File 1). Therefore, the construct was
altered to contain an unmodified N-terminus with Ser at pos-
ition 2. The N-terminal Met is cleaved when followed by small
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Scheme 1: Protein design and dual-functionalization of TTL: periodate cleavage, oxime ligation and CuAAC.
amino acids like glycine, alanine or serine in the native process
of N-terminal methionine excision (NME) [43]. This process
exposes Ser2 at the N-terminus for subsequent N-terminal
oxime ligation. It has to be noted that the incorporation of Aha,
as known [42,44], can hamper NME and therefore delivers in
our case an approximate 1:1 mixture of TTL (estimated by MS,
see Supporting Information File 1) with an N-terminal Ser (Ser-
TTL[Aha]) and an N-terminal Aha (AhaSer-TTL[Aha])
together with nine additional Aha residues (Scheme 1).
However, this N-terminal heterogeneity did not hamper our
subsequent application, since only biotinylated protein could
bind to the chip for SPR studies (see below).
Dual-labeling of TTL
Oxime ligation and CuAAC have been reported previously to
be orthogonal to each other in DNA model systems and proteins
obtained from amber and ochre suppression [24,45,46]. Since
glycol cleavage is needed to generate the N-terminal aldehyde
[39,40], we initialized our synthetic route with NaIO4 treatment
since the galactose units installed by CuAAC would be effi-
cient targets for a glycol cleavage, as shown previously [47].
Based on optimization experiments for the periodate treatment
of N-terminal Ser peptides (data not shown), TTL was treated
with sodium periodate in a phosphate buffer at pH 7 and 15 °C
for 1 h and quenched with N-acetyl-Met to quantitatively form
the aldehyde Ald-TTL[Aha] (Scheme 1, Figure 1A) [48]. For
the oxime ligation with the synthesized biotin hydroxylamine
derivative 1 (see Supporting Information File 1), several reac-
tion conditions were screened to achieve full conversion based
on MALDI–MS analysis for the Ald-TTL[Aha], in which the
unreactive AhaSer-TTL[Aha] served as a reference point
(Figure 1A), whereby it has to be noted that due to the limited
resolution of the MALDI for proteins all detected mass values
differ by a few Dalton from the theoretical masses, and the peak
intensity for the functionalized biotinylated lipase (Gal-0) was
usually lower in all MALDI spectra which was addressed to the
lower detectability of Gal-0 due to the attached biotin. Under
rather mild reaction conditions at pH 7 with p-anisidine as a
catalyst only 10% product was formed [49]. Lowering the pH
and increasing the amount of hydroxylamine 1 promoted the
desired Schiff’s base formation (see Supporting Information
File 1) and full conversion to Gal-0 could be achieved in an am-
monium acetate buffer (100 mM, pH 3.0) with 20 equiv hydrox-
ylamine 1. The successful biotinylation could also be shown by
SDS PAGE (sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis) and Western Blot analysis (see Figure 1B–C,
lane 3).
To probe CuAAC, we first reacted the unmodified protein mix-
ture (Aha)Ser-TTL[Aha] with the previously synthesized
β-butynyl galactose 2 (Scheme 1). The conjugation reaction was
performed in phosphate buffer (100 mM, 100 mM NaCl, pH 7)
with varying amounts of CuSO4. Tris(3-hydroxypropyltri-
azolylmethyl)amine (THPTA), a good stabilizer for Cu(I) in
solution [50], was applied in all coupling reactions and conver-
sions were again checked by MALDI–MS, gel electrophoresis
and Western Blot (Figure 1B,C, lane 4). As evidenced by
MS-analysis, we could observe that both proteins Ser-
TTL[Aha] (nine azides) and AhaSer-TTL[Aha] (ten azides)
reacted with galactose alkyne 2 via CuAAC and different
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Figure 1: Dual-functionalization of TTL: A) MALDI–MS spectra (red: modified protein (as marked below); black: reference protein AhaSer-TTL[Aha];
m/z (calculated): [M+H]+ 31245 Da; for full spectra see Supporting Information File 1) B) SDS PAGE of TTL protein conjugates (Coomassie stain), C)
Western Blot (streptavidin-peroxidase antibody).
degrees of glycosylation could be achieved depending of the
amount of Cu2+ applied in the reaction, though the maximum
number of galactose units per protein that could be attached
appeared to be five (data not shown). By applying a sequential
oxime/CuAAC ligation protocol by applying CuAAC to the
biotinylated protein Gal-0, we could show successful dual-func-
tionalization of our protein. Again, depending on the Cu2+
concentration, different numbers of galactose units per protein
could be achieved. Although a protein mixture of two proteins,
bearing either nine or ten Aha residues which could potentially
react with butynyl galactose 2, the MALDI spectra of the final
protein mixture after CuAAC showed surprisingly sharp peaks
with a difference of only 1–2 galactose units, which might indi-
cate that both proteins react to a similar degree with the alkynyl
galactose 2 (see Supporting Information File 1). Lower concen-
trations of CuSO4 led to higher degrees of functionalization
with 3–4 (10 mol %, Gal-3) galactose units, whereas higher
amounts of Cu2+ led to lower degrees of functionalization with
1–2 clicked sugars (30 mol %, Gal-1). Further evidence for
successful glycan attachment was provided by tryptic digest and
MS/MS-analysis of Gal-3, which showed functionalization of
two specific Aha residues (see Table S5 in Supporting Informa-
tion File 1). It should be noted that higher concentrations of
Cu2+ also led to precipitation and loss of protein material.
Finally, the protein mixture was purified by centrifuge
membrane filtration with a 100 mM phosphate buffer (100 mM
NaCl, pH 7) to yield approximately 20–35% of the initial
protein material (Aha)Ser-TTL[Aha] after dual-functionaliza-
tion as judged by UV (see Supporting Information File 1).
Stability and lectin binding studies
To ensure the stability of TTL throughout the dual-labeling
process, we performed a lipase activity assay to demonstrate
that the enzymatic activity could be retained. All protein
samples thereby showed similar lipase activity, as determined
by the colorimetric p-nitrophenol assay (see Supporting Infor-
mation File 1).
Finally, we also conducted surface plasmon resonance (SPR)
studies to show the general applicability of our dual modified
protein scaffold for measuring lectin binding constants
(Figure 2 and Supporting Information File 1). We first probed
the qualitative binding of Erythrina cristagalli lectin (ECL) to
proteins Gal-1 and Gal-3 as well as Gal-0 as a negative control.
The three protein samples were each immobilized on a strepta-
vidin-coated chip. Then, ECL was passed over the chip at
Beilstein J. Org. Chem. 2015, 11, 784–791.
788
Figure 2: SPR measurements: A) set-up showing different binding events of the double-functionalized TTL to ECL; B) KD-data obtained for binding of
Gal-0, Gal-1 and Gal-3.
different concentrations to determine the relative binding
affinity for the immobilized glycosyl-TTL coated surface. At a
concentration of 10 µM ECL, significant binding of both glyco-
sylated protein samples towards the lectin were obtained (see
Supporting Information File 1). The higher valent Gal-3
revealed enhanced ECL binding, attributed to more frequent
rebinding events. Also cross-binding of ECL to adjacent Gal-3
proteins might occur due to the initial high immobilization
level. In contrast, the non-glycosylated lipase exhibited no
binding at all. To further characterize the binding efficiency,
KD-values were determined by SPR measurements (for set-up
see Supporting Information File 1). Again, for Gal-0 no binding
could be detected. Both glycosylated proteins, Gal-1 and Gal-3,
presented very similar and rather low KD-values (70 and 60
µM, respectively) with a slight tendency for stronger binding
for the higher glycosylated protein Gal-3 (see Supporting Infor-
mation File 1). However, as the two Gal-binding sites of ECL
are localized on opposite sides [51], our rather short butynyl
linker might not be able to fully bend around the protein to
achieve a multivalent effect [8,52], which might be the reason
for the small difference between the two KD values. In future
experiments, different linker lengths should be probed to allow
better binding of multiple carbohydrate units of one protein
scaffold with multiple binding sites of one lectin molecule.
Conclusion
In conclusion, we succeeded in the incorporation of two unnat-
ural functional groups, namely azides and aldehydes, into a
protein by combining a simple supplementation based incorpor-
ation and well-known oxidative periodate cleavage. To the best
of our knowledge, this is the first successful combination of
co-translational NCAA incorporation with post-translational
periodate oxidation, which provides a novel tool to obtain a
protein with two unnatural functional groups. For the function-
alization of these unnatural moieties, we combined CuAAC
with oxime ligation for the attachment of two different ligands,
galactose and biotin, to the thermostable lipase TTL. The
double functionalized TTL scaffold exhibited lectin binding
properties while conserving its natural enzymatic activity,
thereby demonstrating the principle applicability of this double
protein functionalization strategy to the generation of new
multivalent binding scaffolds.
Currently, we are further expanding our general dual-labeling
strategy to other protein scaffolds as well as NCAAs to provide
multiple distinct probes for the generation of individually
designed protein binders. An important parameter in the future
will be the combination with protein modelling as well as the
implementation of different linker lengths between the protein
and the binding units, to engineer precise protein models and
study a variety of multivalent receptors.
Experimental
General protocol for glycol cleavage and oxime ligation on
TTL. A solution of the TTL (12 µM; 100 mM phosphate
buffer, 100 mM NaCl, pH 7) was mixed with NaIO4 (3 equiv)
and shaken for 1 h at 15 °C. N-Acetyl-Met (12 equiv)
was added to the mixture and shaken for 1 h at 15 °C. The
buffer was exchanged by centrifuge membrane filtration
(14000 r/min). For the different buffers and catalysts see Table
S1 (Supporting Information File 1). Biotin hydroxylamine 1
was added to the protein solution and the mixture was shaken
overnight at 15 °C. For MALDI–MS analysis, the solutions
were centrifuge-filtered (14000 r/min) and washed 4× with am-
monium acetate solution (100 mM, pH 7) and 4× with ultrapure
water. The proteins were analyzed by MALDI–MS measure-
ments (Tables S3 and S4, Supporting Information File 1) and by
SDS PAGE (Coomassie stain) and Western Blotting (strepta-
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vidin–peroxidase antibody, 1:1000) using a Mini-Protean Tetra
cell system (BioRad) (see Figure 1).
For subsequent dual-functionalization, the samples were
centrifuge-filtered with Dulbecco’s PBS buffer (100 mM, pH 7)
after oxime ligation and directly applied in the CuAAC.
General protocol for CuAAC on TTL. A solution of the TTL
(10 µM; 100 mM phosphate buffer, 100 mM NaCl, pH 7) was
mixed with CuSO4 (1 M in 100 mM phosphate buffer, 100 mM
NaCl, pH 7), sodium ascorbate (50 equiv to Cu2+) and 1-O-but-
3-ynyl-α-galactopyranoside (2) (1100 equiv to protein), 80 µL
THPTA (5 equiv to Cu2+), and aminoguanidine (8 mM) and
shaken overnight at 15 °C. For the different CuSO4 concentra-
tions see Table S2 (Supporting Information File 1). The solu-
tions were centrifuge-filtered (14000 r/min) and washed 3× with
buffer/EDTA-solution (100 mM phosphate buffer, 100 mM
NaCl, 5 mM EDTA, pH 7) and 4× with ultrapure water. The
proteins were analyzed by MALDI–MS measurements (Tables
S3 and S4, Supporting Information File 1) and by SDS PAGE
(Coomassie stain) and Western blotting (streptavidin–peroxi-
dase antibody, 1:1000) using a Mini-Protean Tetra cell system
(BioRad) (see Figure 1). Protein concentrations were checked
by UV (λ = 280 nm).
Lipase activity test [53]. Lipase activity was determined by
measuring the hydrolysis of p-nitrophenyl palmitate (pNPP;
Sigma). Solution A (10 mM p-nitrophenyl palmitate in 10 mL
ethanol) and solution B (100 mg gummi arabicum in 90 mL
Tris-HCl buffer (50 mM, pH 8)) were mixed 1:9 and dispersed
(ultraturrax, 3 min, 20000 min−1) to get solution C. For each
measurement, 450 µL of solution C were mixed with 50 µL
enzyme solution (0.13 nmol protein). The contribution of auto-
hydrolysis was assessed by including a blank that contained the
same volume of 50 mM Tris·HCl pH 8.0 instead of enzyme
(background measurement). The samples were shaken at 50 °C
for 1 h. Absorbance of released p-nitrophenol was measured at
λ = 410 nm (Figure S10, Supporting Information File 1).
Surface-plasmon-resonance (SPR). SPR measurements were
performed on a BiacoreX (GE Healthcare, Freiburg, Germany).
Biotinylated TTL samples were coupled to streptavidin func-
tionalized gold chips (SA-Chips, GE Healthcare, Freiburg,
Germany). Before immobilization, the sensor chip was condi-
tioned with three consecutive 1 min injections of 1 M NaCl and
50 mM NaOH.
For initial binding experiments, flow cell 2 (Fc2) of each chip
was fully loaded (≈400 RU) with our protein. Flow cell 1 (Fc1)
remained untreated and served as a reference. After immobili-
zation, a sample volume of 100 µL of different concentrations
of ECL solutions (1 or 10 µM) in HEPES buffered saline with
calcium (HBS-Ca), 20 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), pH 7.4, 150 mM NaCl, 1 mM
CaCl2 were injected over both lanes at a flow rate of 30 µL/min.
The final binding signals were obtained by subtracting the
resulting response units (RU) of the free reference lane from the
data obtained for the sample lane (Fc2-Fc1, Figure S11,
Supporting Information File 1). The association phase was fol-
lowed by a 180 s dissociation phase. Washing and regenerating
of both lanes was done by injecting 4 M MgCl2.
For KD determination, chips were loaded to one third with the
respective TTL and 50 µL ECL were injected in each run with a
“wash after injection” step of 180 s for the dissociation phase,
recording the response difference between ligand flow cell and
reference flow cell. Washing and regeneration was done again
by injecting 4 M MgCl2. Kinetic measurements consisted of at
least five different concentrations ECL (1, 2, 10, 20 and
100 µL), while one of them was determined twice; additionally
one blank was included. For every protein sample (Gal-1 and
Gal-3), KDs were determined twice. For the TTL without galac-
tose units (Gal-0), binding was measured once at the highest
possible lectin concentration (100 µM). Data were aligned and
after additional subtraction of the blank measurement from each
sensorgram (Figures S12–S14, Supporting Information File 1),
analyzed on equilibrium binding by nonlinear curve fitting of
the Langmuir binding isotherm (Figures S15 and S16,
Supporting Information File 1).
Supporting Information
Details on materials, protein design, construction of the
expression plasmids, protein expression and purification,
mass spectrometry data for the expressed proteins, general
methods, synthetic protocols and analytical data (including
1H, 13C and 19F NMR spectra) for compounds 1 and 2,
reaction conditions for the ligation strategies, SDS PAGE
and Western Blot lanes are provided as Supporting
Information.
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